Structural and biochemical characterization of human Schlafen 5
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The Schlafen family belongs to the interferon-stimulated genes and its members are involved in cell cycle regulation, T cell quiescence, inhibition of viral replication, DNA-repair and tRNA processing. Here, we present the cryo-EM structure of full-length human Schlafen 5 (SLFN5) and the high-resolution crystal structure of the highly conserved N-terminal core domain. We show that the core domain does not resemble an ATPase-like fold and neither binds nor hydrolyzes ATP. SLFN5 binds tRNA as well as single- and double-stranded DNA, suggesting a potential role in transcriptional regulation. Unlike rat Slfn13 or human SLFN11, human SLFN5 did not cleave tRNA. Based on the structure, we identified two residues in proximity to the zinc finger motif that decreased DNA binding when mutated. These results indicate that Schlafen proteins have divergent enzymatic functions and provide a structural platform for future biochemical and genetic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Terwilliger, T. C., Grosse-Kunstleve, R. W., Afonine, P. V., Moriarty, N. W., Zwart, P. H., Hung, L.-W., Read, R. J., & Adams, P. D. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744490705024x · Cited by 1,462
Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11
Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T. E., Landry, S., Pan, T., Weitzman, M. D., et al. (2012) · Nature · doi:10.1038/nature11433 · Cited by 375
SLFN11 Blocks Stressed Replication Forks Independently of ATR
Murai, J., Tang, S.-W., Leo, E., Baechler, S. A., Redon, C. E., Zhang, H., Al Abo, M., Rajapakse, V. N., Nakamura, E., Jenkins, L. M. M., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.012 · Cited by 275 · cited 2×
“In addition, it sensitizes cancer cells to DNA targeting therapies by blocking replication in response to DNA damage sites (32).”
DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs
Li, M., Kao, E., Malone, D., Gao, X., Wang, J. Y. J., & David, M. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0142-5 · Cited by 136 · cited 5×
“The Nterminal domain of SLFN11 was shown to specifically cleave type II tRNAs (31).”
InfluentialYang, J.-Y., Deng, X.-Y., Li, Y.-S., Ma, X.-C., Feng, J.-X., Yu, B., Chen, Y., Luo, Y.-L., Wang, X., Chen, M.-L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03544-x · Cited by 124 · cited 10×
“The structure of SLFN51–336 shows similarity to the published structure of the N-terminal domain of rat Slfn13 (rSlfn1314–353) (Supplementary Figure S8E) (42).”
InfluentialIdentification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics
de Waal, L., Lewis, T. A., Rees, M. G., Tsherniak, A., Wu, X., Choi, P. S., Gechijian, L., Hartigan, C., Faloon, P. W., Hickey, M. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1984 · Cited by 96
Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase
Garvie, C. W., Wu, X., Papanastasiou, M., Lee, S., Fuller, J., Schnitzler, G. R., Horner, S. W., Baker, A., Zhang, T., Mullahoo, J. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24495-w · Cited by 85 · cited 4×
“Since human SLFN12 and rSlfn13 have been shown to cleave rRNA and tRNAs, respectively (42,45), we superimposed the available structures to further investigate the active sites (Figure 5C, D).”
InfluentialShee, K., Wells, J. D., Jiang, A., & Miller, T. W. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224267 · Cited by 43
Research works printed but not linked: 70
- Schwarz, 1998, Schlafen, a new family of growth regulatory genes that affect thymocyte development, Immunity, 9, 657, 10.1016/S1074-7613(00)80663-9 · DOI · Paper page
- Geserick, 2004, Modulation of t cell development and activation by novel members of the schlafen (slfn) gene family harbouring an RNA helicase-like motif, Int. Immunol., 16, 1535, 10.1093/intimm/dxh155 · DOI · Paper page
- Katsoulidis, 2009, Role of schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses, J. Biol. Chem., 284, 25051, 10.1074/jbc.M109.030445 · DOI · Paper page
- Katsoulidis, 2010, Role of interferon {alpha} (IFN{alpha})-inducible schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells, J. Biol. Chem., 285, 40333, 10.1074/jbc.M110.151076 · DOI · Paper page
- Brady, 2005, Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin d1, J. Biol. Chem., 280, 30723, 10.1074/jbc.M500435200 · DOI · Paper page
- Kuang, 2014, Schlafen 1 inhibits the proliferation and tube formation of endothelial progenitor cells, PLoS One, 9, e109711, 10.1371/journal.pone.0109711 · doi:10.1371/journal.pone.0109711
- Berger, 2010, An slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence, Nat. Immunol., 11, 335, 10.1038/ni.1847 · DOI · Paper page
- Puck, 2015, Expression and regulation of schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and t cells, Results Immunol, 5, 23, 10.1016/j.rinim.2015.10.001 · DOI
- Puck, 2017, The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep t cells in a quiescent state, Eur. J. Immunol., 47, 193, 10.1002/eji.201646405 · DOI
- Goldshtein, 2016, Loss of T-cell quiescence by targeting slfn2 prevents the development and progression of T-ALL, Oncotarget, 7, 46835, 10.18632/oncotarget.9390 · DOI
- Omar, 2016, Schlafen2 mutation unravels a role for chronic ER stress in the loss of t cell quiescence, Oncotarget, 7, 39396, 10.18632/oncotarget.9818 · DOI
- Basson, 2018, Schlafen 12 interaction with serpinb12 and deubiquitylases drives human enterocyte differentiation, Cell. Physiol. Biochem., 48, 1274, 10.1159/000492019 · DOI
- Kovalenko, 2014, Schlafen 12 expression modulates prostate cancer cell differentiation, J. Surg. Res., 190, 177, 10.1016/j.jss.2014.03.069 · DOI
- Lee, 2008, RANKL-induced schlafen2 is a positive regulator of osteoclastogenesis, Cell. Signal., 20, 2302, 10.1016/j.cellsig.2008.08.019 · DOI
- Mavrommatis, 2013, Expression and regulatory effects of murine schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma, J. Biol. Chem., 288, 33006, 10.1074/jbc.M113.460741 · DOI
- Tian, 2014, Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan, Anticancer Drugs, 25, 1175, 10.1097/CAD.0000000000000151 · DOI · Paper page
- Zoppoli, 2012, Putative DNA/RNA helicase schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents, Proc. Natl. Acad. Sci. U.S.A., 109, 15030, 10.1073/pnas.1205943109 · DOI · Paper page
- Barretina, 2012, The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 · DOI · Paper page
- Nogales, 2016, Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs, Oncotarget, 7, 3084, 10.18632/oncotarget.6413 · DOI · Paper page
- Lok, 2017, PARP inhibitor activity correlates with SLFN11 expression and demonstrates synergy with temozolomide in small cell lung cancer, Clin. Cancer Res., 23, 523, 10.1158/1078-0432.CCR-16-1040 · DOI · Paper page
- Murai, 2016, Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition, Oncotarget, 7, 76534, 10.18632/oncotarget.12266 · DOI · Paper page
- Gardner, 2017, Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis, Cancer Cell, 31, 286, 10.1016/j.ccell.2017.01.006 · DOI · Paper page
- Seong, 2017, Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication, Immunobiology, 222, 979, 10.1016/j.imbio.2017.07.002 · DOI
- Kim, 2021, Comparative proteomics identifies schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription, Nat Microbiol, 6, 234, 10.1038/s41564-020-00826-3 · DOI
- Chaturvedi, 2014, The P-loop region of schlafen 3 acts within the cytosol to induce differentiation of human caco-2 intestinal epithelial cells, Biochim. Biophys. Acta, 1843, 3029, 10.1016/j.bbamcr.2014.09.017 · DOI
- Neumann, 2008, Subcellular localization of the schlafen protein family, Biochem. Biophys. Res. Commun., 370, 62, 10.1016/j.bbrc.2008.03.032 · DOI
- Omar, 2017, Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis, Immunology, 152, 484, 10.1111/imm.12785 · DOI
- Fischietti, 2018, Slfn2 regulates type i interferon responses by modulating the NFkB pathway, Mol. Cell. Biol., 38, e00053-18, 10.1128/MCB.00053-18 · DOI
- Winkler, 2021, SLFN11 informs on standard of care and novel treatments in a wide range of cancer models, Br. J. Cancer, 124, 951, 10.1038/s41416-020-01199-4 · DOI
- Rathkey, 2020, Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-schlafen 11 and Low-O6-methylguanine-DNA methyltransferase expression, J. Thorac. Oncol., 15, 843, 10.1016/j.jtho.2020.01.012 · DOI · Paper page
- Takashima, 2021, Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers, Br. J. Cancer, 125, 65, 10.1038/s41416-021-01364-3 · DOI
- Coussy, 2020, BRCAness, SLFN11, and RB1 loss predict response to topoisomerase i inhibitors in triple-negative breast cancers, Sci. Transl. Med., 12, eaax2625, 10.1126/scitranslmed.aax2625 · DOI
- Kang, 2015, Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression, Clin. Cancer Res., 21, 1139, 10.1158/1078-0432.CCR-14-1882 · DOI · Paper page
- Allison Stewart, 2017, Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer, Oncotarget, 8, 28575, 10.18632/oncotarget.15338 · DOI · Paper page
- Okamoto, 2021, SLFN11 promotes stalled fork degradation that underlies the phenotype in fanconi anemia cells, Blood, 137, 336, 10.1182/blood.2019003782 · DOI
- Murai, 2021, SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243, Cancer Res., 81, 3067, 10.1158/0008-5472.CAN-20-2694 · DOI
- Fletcher, 2018, Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation, RNA, 24, 939, 10.1261/rna.066415.118 · DOI
- Pisareva, 2015, Characterization of novel ribosome-associated endoribonuclease SLFN14 from rabbit reticulocytes, Biochemistry, 54, 3286, 10.1021/acs.biochem.5b00302 · DOI · Paper page
- Sassano, 2015, Human schlafen 5 (SLFN5) is a regulator of motility and invasiveness of renal cell carcinoma cells, Mol. Cell. Biol., 35, 2684, 10.1128/MCB.00019-15 · DOI
- Gu, 2020, SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer, Am J Cancer Res, 10, 2832
- Arslan, 2017, Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma, Oncogene, 36, 6006, 10.1038/onc.2017.205 · DOI
- Companioni Napoles, 2017, SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer, J. Gastroenterol., 52, 39, 10.1007/s00535-016-1202-4 · DOI
- Wan, 2020, Human schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription, Br. J. Cancer, 123, 633, 10.1038/s41416-020-0873-z · DOI
- Wan, 2019, SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3beta/beta-catenin pathway, Cell. Signal., 59, 1, 10.1016/j.cellsig.2019.03.004 · DOI
- Kabsch, 2010, Integration, scaling, space-group assignment and post-refinement, Acta Crystallogr. D. Biol. Crystallogr., 66, 133, 10.1107/S0907444909047374 · DOI · Paper page
- Kabsch, 2010, Xds, Acta Crystallogr. D. Biol. Crystallogr., 66, 125, 10.1107/S0907444909047337 · DOI · Paper page
- Grosse-Kunstleve, 2003, Substructure search procedures for macromolecular structures, Acta Crystallogr. Sect. D, 59, 1966, 10.1107/S0907444903018043 · DOI · Paper page
- Terwilliger, 2009, Decision-making in structure solution using bayesian estimates of map quality: the PHENIX autosol wizard, Acta Crystallogr. Sect. D, 65, 582, 10.1107/S0907444909012098 · DOI · Paper page
- Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D. Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
- Stein, 2008, CHAINSAW: a program for mutating pdb files used as templates in molecular replacement, J. Appl. Crystallogr., 41, 641, 10.1107/S0021889808006985 · DOI · Paper page
- Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D. Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
- McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
- McCoy, 2013, SCEDS: protein fragments for molecular replacement in phaser, Acta Crystallogr. Sect. D, 69, 2216, 10.1107/S0907444913021811 · doi:10.1107/s0907444913021811
- Afonine, 2012, Towards automated crystallographic structure refinement with phenix.refine, Acta Crystallogr. D. Biol. Crystallogr., 68, 352, 10.1107/S0907444912001308 · DOI · Paper page
- Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D, 53, 240, 10.1107/S0907444996012255 · DOI · Paper page
- Vagin, 2004, REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use, Acta Crystallogr. Sect. D, 60, 2184, 10.1107/S0907444904023510 · DOI · Paper page
- Emsley, 2010, Features and development of coot, Acta Crystallogr. Sect. D, 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
- Pettersen, 2021, UCSF chimerax: structure visualization for researchers, educators, and developers, Protein Sci., 30, 70, 10.1002/pro.3943 · DOI · Paper page
- Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat. Methods, 14, 331, 10.1038/nmeth.4193 · DOI · Paper page
- Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 · DOI · Paper page
- Punjani, 2020, Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction, Nat. Methods, 17, 1214, 10.1038/s41592-020-00990-8 · DOI · Paper page
- Lowary, 1998, New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning, J. Mol. Biol., 276, 19, 10.1006/jmbi.1997.1494 · DOI · Paper page
- Schneider, 2012, NIH image to imagej: 25 years of image analysis, Nat. Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
- Murai, 2020, Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress, Cell Rep., 30, 4137, 10.1016/j.celrep.2020.02.117 · DOI
- Jeong, 2003, Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of chk1 during ATR-mediated activation, J. Biol. Chem., 278, 46782, 10.1074/jbc.M304551200 · DOI
- Zhang, 2014, The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop, Cell Rep., 6, 421, 10.1016/j.celrep.2014.01.003 · DOI · Paper page
- Tanaka, 2012, STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway, Sci. Signal, 5, ra20, 10.1126/scisignal.2002521 · DOI · Paper page
- Walker, 1982, Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold, EMBO J., 1, 945, 10.1002/j.1460-2075.1982.tb01276.x · DOI · Paper page
- Yue, 2021, SLFN2 protection of tRNAs from stress-induced cleavage is essential for t cell-mediated immunity, Science, 372, eaba4220, 10.1126/science.aba4220 · DOI
- Chen, 2019, Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinB12 in transcriptional regulation, J. Mol. Graph. Model., 90, 59, 10.1016/j.jmgm.2019.04.003 · DOI
Cited by
piRNA processing by a trimeric Schlafen-domain nuclease
Podvalnaya, N., Bronkhorst, A. W., Lichtenberger, R., Hellmann, S., Nischwitz, E., Falk, T., Karaulanov, E., Butter, F., Falk, S., & Ketting, R. F. (2023) · Nature · doi:10.1038/s41586-023-06588-2 · Cited by 47
Structural Bioinformatics and Deep Learning of Metalloproteins: Recent Advances and Applications
Andreini, C., & Rosato, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147684 · Cited by 25
Legrand, A., Dahoui, C., De La Myre Mory, C., Noy, K., Guiguettaz, L., Versapuech, M., Loyer, C., Pillon, M., Wcislo, M., Guéguen, L., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002696 · Cited by 18
Phosphorylation-mediated conformational change regulates human SLFN11
Kugler, M., Metzner, F. J., Witte, G., Hopfner, K.-P., & Lammens, K. (2024) · Nature Communications · doi:10.1038/s41467-024-54833-7 · Cited by 13
“The manuscript still provides important advances in the understanding of SLFN11 regulation, however, the experimental and textual issues have to be resolved before publishing.”
Self-citationpiRNA processing by a trimeric Schlafen-domain nuclease
Podvalnaya, N., Bronkhorst, A. W., Lichtenberger, R., Hellmann, S., Nischwitz, E., Falk, T., Karaulanov, E., Butter, F., Falk, S., & Ketting, R. F. (2023) · doi:10.1101/2023.01.19.524756 · Cited by 3
Metadata
- Authors
- Metzner, F. J., Huber, E., Hopfner, K.-P., & Lammens, K.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-01-17
- Volume
- 50
- Issue
- 2
- Pages
- 1147-1161
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W4205335652
- Cited by
- 41
- References
- 9
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Deutsche Forschungsgemeinschaft (210592381)
- European Research Council (INO3D)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural and biochemical characterization of human Schlafen 5. https://app.cochat.ai/papers/10.1093/nar/gkab1278
- The paper
- Metzner, F. J., Huber, E., Hopfner, K.-P., & Lammens, K. (2022). Structural and biochemical characterization of human Schlafen 5. Nucleic Acids Research. https://doi.org/10.1093/nar/gkab1278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.